Brain targeted low molecular weight hydrophobic antioxidant compounds
US6420429B1 · kind B1 · utility
18Cited by
4References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 1, 1999 |
| Grant date | Jul 16, 2002 |
| Priority date | — |
| Expiry date | Jun 1, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel brain targeted low molecular weight, hydrophobic antioxidants and use of antioxidants in treatment of central nervous system neurodegenerative disorders such as Parkinson's, Alzheimer's and Creutzfeldt-Jakob's diseases and in treatment of conditions of peripheral tissues, such as acute respiratory distress syndrome, amyotrophic lateral sclerosis, atheroscierotic cardiovascular disease and multiple organ dysfunction, in which oxidants are overproduced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.